Core Points - The stock price of Weigao Blood Products fell by 2.48% on October 17, with a trading volume of 81.58 million yuan [1] - The company had a net financing buy of -620,500 yuan on the same day, with a total financing and securities balance of 106 million yuan [1] - As of June 30, the number of shareholders decreased by 47.45% to 31,400, while the average circulating shares per person increased by 90.29% to 1,213 shares [2] Financial Performance - For the first half of 2025, Weigao Blood Products reported a revenue of 1.765 billion yuan, representing a year-on-year growth of 8.52% [2] - The net profit attributable to shareholders for the same period was 220 million yuan, showing a year-on-year increase of 10.11% [2] Dividend Information - Since its A-share listing, Weigao Blood Products has distributed a total of 65.82 million yuan in dividends [3]
威高血净10月17日获融资买入715.84万元，融资余额1.06亿元